Journals / Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi / 2021 / Cilt: 35 - Sayı: 3

Our Five Years Experiences of Arteriovenous Fistula For Hemodialysis

Beş Yıllık Hemodiyaliz Amaçlı Arteriovenöz Fistül Deneyimlerimiz

Pages
189–194
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: There was a statistically significant relationship between diabetes and 1-year occlusion rates (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: End-stage renal disease is an important health problem.
📊
Key Findings & Data:Among these access routes, arteriovenous fistulas have the least complications and longest patency rates.
💡
Conclusion & Impact:Results: There was a statistically significant relationship between diabetes and 1-year occlusion rates (p
🔬Design:Research Article
📍Scope:2016-2020 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: End-stage renal disease is an important health problem. Haemodialysis is inevitable for these patients. In order to apply the dialysis, a vascular access pathway is required. Among these access routes, arteriovenous fistulas have the least complications and longest patency rates. Materials and Methods: Between January 2016-2020, 406 patients who were referred for arteriovenous fistula operation for hemodialysis were analyzed. 213 patients with radiocephalic fistula were named as Group I, 104 patients with brachiocephalic fistula were named as Group II, and 89 patients who underwent revision of inadequate fistula were named as Group III. The 1-year patency rates were studied and the relationship with comorbidities and gender were analyzed. Results: There was a statistically significant relationship between diabetes and 1-year occlusion rates (p

Özet

Amaç: Son dönem böbrek yetmezliği tüm dünyada olduğu gibi ülkemizde de önemli bir sağlık sorunudur. Bu hastaların hayatlarını idame ettirebilmeleri için diyaliz kaçınılmazdır. Hemodiyaliz ile diyaliz ihtiyaçlarının karşılanabilmesi içinde damar erişim yolu gerekmektedir. Arteriovenöz fistüller bu erişim yolları arasında en az komplikasyona sahip aynı zamanda en uzun süre açıklık oranları ile öne çıkmaktadır. Gereç-Yöntem: Ocak 2016-Ocak 2020 tarihleri arasında hemodiyaliz amaçlı arterio-venöz fistül açılması amacıyla gelen 406 hasta incelendi. Radyosefalik fistül açılan 213 hasta Grup I, brakiyosefalik fistül açılan 104 hasta Grup II, daha önceden açılmış olan fistüle revizyon yapılan 89 hasta da Grup III olarak adlandırıldı. Her üç grup için alınan hastaların 1 yıllık açıklık oranları, bu açıklık oranlarının eşlik eden hastalıklar ve cinsiyet ile olan ilişkisi istatistiksel olarak incelendi. Bulgular: Grupların verileri incelendiğinde Grup I'de diabet ile 1 yıllık tıkanma arasında istatistiksel olarak anlamlı ilişki olduğu saptandı (p

🔖

Cite This Article

ÖZGÜLER, İ. M., ÜSTÜNEL, L. (2022). Our Five Years Experiences of Arteriovenous Fistula For Hemodialysis. Fırat Üniversitesi Sağlık Bilimleri Tıp Dergisi, Cilt: 35 - Sayı: 3, 189–194. https://ajindex.com/articles/514405

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Paraskevas KI, Bessias N, Koupidis SA, et al. Incidence of end-stage renal disease in the elderly: A steadily rising global socioeconomic epidemic. Int Urol Nephrol 2010; 42: 523-525
  2. Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: An instrumental variable analysis. Am J Kidney Dis 2009; 53: 475-491
  3. McGrogan DG, Field MA, Maxwell AP, Marie Y, Inston NG. Patient survival following arteriovenous fistula formation. J Vasc Access 2015; 16: 195-199
  4. National Kideny Foundation K/DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48: 176-247
  5. Roy-Chaudhury P, Arend L, Zhang J, et al. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis 2007; 50: 782-790
  6. Dember LM, Imrey PB, Beck GJ, et al. Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis 2014; 63:104-112
  7. Lee T and Misra S. New insights into dialysis vascular access: molecular targets in arteriovenous fistula and arteriovenous graft failure and their potential to improve vascular access outcomes. Clin J Am Soc Neprol 2016; 11: 1504-1512
  8. Roy-Chaudhury P, Wang Y, Krishnamoorthy M, et al. Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant 2009; 24: 2786-2791
  9. Santoro D, Benedetto F, Mondello P, et al. Vascular access for hemodialysis: current perspectives. Int J Nephrol Renovasc Dis 2014; 7: 281-294
  10. Hu D, Li C, Sun L, et al. A modified nontransposed brachiobasilic arteriovenous fistula versus brachiocephalic arteriovenous fistula for maintenance hemodialysis access. J Vasc Surg 2016; 64: 1059-1065
  11. Viecelli AK, O'Lone E, Sautenet B, et al. Vascular access outcomes reported in maintenance hemodialysis trials: a systematic review. Am J Kidney Dis 2018; 71: 382-391
  12. Slinin Y, Greer N, Ishani A, et al. Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline. Am J Kidney Dis 2015; 66: 823- 836
  13. Huijbregts HJT, Bots ML, Wittens CHA. On behalf of the CIMINO study group. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol 2008; 3: 714-719
  14. Mousa AY, Dearing DD, AbuRahma AF. Radiocephalic fistula: review and update. Ann Vasc Surg 2013; 27: 370- 378
  15. Bharat A, Jaenicke M,